Ophthalmology – Thyroid Optic Neuropathy

What the Disorder Represents

Thyroid optic neuropathy, more commonly termed dysthyroid optic neuropathy (DON), is the most important sight-threatening neurologic complication of thyroid eye disease (TED).

It usually results from:

Compression of the optic nerve at the orbital apex by enlarged extraocular muscles

and can cause:

• Reduced visual acuity
• Color desaturation
• Relative afferent pupillary defect
• Visual-field loss
• Permanent optic atrophy if treatment is delayed

DON is an:

Ophthalmic emergency.

Relationship to Thyroid Eye Disease

TED is an autoimmune orbital disorder most commonly associated with:

Graves disease

but may also occur in patients who are:

• Euthyroid
• Hypothyroid
• Occasionally associated with Hashimoto thyroiditis

Therefore:

Normal thyroid hormone levels do not exclude TED or DON.

Why the Optic Nerve Becomes Compromised

TED causes inflammatory enlargement of:

• Extraocular muscles
• Orbital fat
• Connective tissue

Within the fixed bony orbit, enlarged extraocular muscles can crowd the:

Orbital apex

and compress the optic nerve and its vascular supply.

This is the principal mechanism of DON.

Less Common Mechanisms of Optic Neuropathy

Optic nerve dysfunction may also occasionally result from:

• Severe proptosis with optic nerve stretch
• Orbital vascular congestion
• Increased orbital pressure
• Ischemic compromise

However, the classic mechanism is:

Apical muscle crowding.

Modern Understanding of TED Autoimmunity

Orbital fibroblasts express:

• TSH receptor
• IGF-1 receptor

Autoimmune stimulation leads to:

• Cytokine release
• Glycosaminoglycan accumulation
• Tissue edema
• Adipogenesis
• Extraocular muscle enlargement

The enlarged muscles are particularly important in:

DON.

Who Is at Greater Risk

DON is more likely in patients with:

• Older age
• Male sex
• Smoking
• Severe extraocular muscle enlargement
• Diabetes
• Active TED
• Poor thyroid control

A particularly important phenotype is:

Severe muscle enlargement with relatively little proptosis.

Why Minimal Proptosis Can Be Dangerous

Marked proptosis can partially decompress orbital pressure anteriorly.

In contrast, some patients have:

• Large extraocular muscles
• Tight orbital septum
• Crowded apex

without dramatic forward displacement of the globe.

Thus:

Absence of severe proptosis does not exclude DON.

This is a classic examination trap.

Typical Patient Complaints

Patients may report:

• Reduced vision
• Loss of color intensity
• “Washed-out” colors
• Reduced contrast
• Visual-field loss
• Diplopia
• Orbital pressure
• Pain with eye movement

Some patients notice very little initially despite significant optic nerve dysfunction.

Why Color Vision Is So Important

One of the earliest clues to DON may be:

Reduced color saturation

particularly red desaturation.

Color vision may deteriorate before substantial Snellen visual acuity loss.

Testing can include:

• Ishihara plates
• Hardy-Rand-Rittler plates
• Comparison of red saturation between eyes

Visual Acuity Findings

Visual acuity may range from:

• Normal
• Mildly reduced
• Profoundly reduced

A normal Snellen acuity does:

Not completely exclude early DON.

Therefore optic nerve assessment should incorporate:

• Color vision
• Pupils
• Visual fields
• Imaging
• Clinical course

Pupillary Examination

An:

RAPD

strongly supports asymmetric optic nerve dysfunction.

However, DON is commonly:

Bilateral

so a patient with symmetric bilateral disease may have:

• No RAPD

despite significant optic neuropathy.

Visual-Field Abnormalities

Field loss is variable.

Possible defects include:

• Central scotoma
• Cecocentral defect
• Paracentral defects
• Arcuate abnormalities
• Altitudinal defects
• Generalized depression

There is no single pathognomonic field pattern.

Optic Disc Appearance

The optic disc may show:

• Normal appearance
• Mild edema
• Hyperemia
• Pallor in chronic disease

An important point is:

A normal optic disc does not exclude DON.

Most compression occurs posteriorly at the orbital apex.

Other TED Findings That Support the Diagnosis

Patients commonly have some combination of:

• Upper-lid retraction
• Lid lag
• Proptosis
• Chemosis
• Conjunctival injection
• Caruncular inflammation
• Restrictive strabismus
• Exposure keratopathy

However, severe external inflammation is not required for DON.

Motility Pattern

Extraocular muscle enlargement commonly affects:

• Inferior rectus
• Medial rectus
• Superior rectus/levator complex
• Lateral rectus less commonly

Typical consequences include:

• Limited elevation
• Limited abduction
• Restrictive hypotropia
• Esotropia

Why Diplopia Occurs

Diplopia results from:

Mechanical restriction

rather than a cranial nerve palsy.

Affected muscles become:

• Edematous during active disease
• Fibrotic during inactive disease

Intraocular Pressure

IOP may be elevated because of:

• Orbital congestion
• Tight inferior rectus
• Elevated episcleral venous pressure
• Steroid treatment

IOP should generally be measured in:

Primary gaze

because forced upgaze can artificially raise the pressure.

Essential Clinical Examination

A patient with suspected DON should undergo:

• Visual acuity
• Pupillary examination
• Color vision
• Contrast sensitivity when available
• Automated visual field
• Ocular motility
• Alignment
• Corneal assessment
• Exophthalmometry
• IOP
• Dilated optic nerve examination

Laboratory Assessment

Useful thyroid studies include:

• TSH
• Free T4
• T3 when appropriate
• TRAb
• TSI

The presence of thyroid autoantibodies supports TED.

Negative antibodies do:

Not absolutely exclude the diagnosis.

Imaging Is Essential When DON Is Suspected

Orbital imaging is generally required.

Preferred studies are:

• CT orbit
• MRI orbit

The main purpose is to assess:

Orbital apex crowding.

Classic CT Findings

CT commonly demonstrates:

• Extraocular muscle belly enlargement
• Relative tendon sparing
• Apical crowding
• Compression of surrounding orbital fat
• Proptosis
• Increased orbital fat in some patients

Inferior and medial recti are often most enlarged.

The “Muscle Index”

Older literature sometimes quantified apical crowding with a:

Muscle index

based on the proportion of orbital width occupied by enlarged muscles.

It can support the diagnosis but is not required routinely.

Clinical and imaging correlation is more important than a single numeric cutoff.

Apical Crowding

The most important radiologic clue is:

Loss of normal fat around the optic nerve at the orbital apex because of enlarged rectus muscles.

This finding strongly supports compressive DON.

Why MRI Can Help

MRI provides superior soft-tissue contrast and may demonstrate:

• Muscle enlargement
• Apical compression
• Optic nerve changes
• Orbital fat expansion

T2/STIR signal can help estimate:

Inflammatory activity.

Tendon Sparing

TED classically causes:

Muscle belly enlargement with relative sparing of the tendons.

This contrasts with idiopathic orbital myositis, in which tendon involvement is more common.

The distinction is useful but:

Not absolute.

Important Differential Diagnoses

Consider:

• Optic neuritis
• Ischemic optic neuropathy
• Compressive orbital tumor
• Orbital lymphoma
• Idiopathic orbital inflammation
• Sarcoidosis
• IgG4-related orbital disease
• Orbital metastasis
• Carotid-cavernous fistula
• Glaucoma

Distinguishing DON From Optic Neuritis

Optic neuritis more commonly shows:

• Pain with eye movement
• Younger age
• Rapid visual loss
• MRI optic nerve enhancement

DON instead occurs in the setting of:

• TED
• Enlarged extraocular muscles
• Apical crowding

Distinguishing DON From Glaucoma

Both may produce:

• Optic neuropathy
• Visual-field loss

DON is suggested by:

• Reduced color vision
• Rapid progression
• Apical compression
• TED signs

Glaucoma more typically causes:

• Characteristic cupping
• RNFL loss
• Corresponding arcuate field defects

Distinguishing TED From Myasthenia

Myasthenia gravis can coexist with autoimmune thyroid disease.

Consider MG when there is:

• Fluctuating diplopia
• Ptosis
• Fatigability
• Variable motility pattern

MG does not typically produce:

• Proptosis
• Extraocular muscle enlargement
• Apical crowding

Activity vs Severity

DON represents:

Sight-threatening severity

regardless of the Clinical Activity Score.

A patient may have optic neuropathy even with a relatively low:

CAS

so a low CAS should never delay treatment.

Immediate Management Goal

The priority is:

Rapid decompression of the optic nerve and suppression of orbital inflammation before irreversible axonal loss occurs.

Treatment should not be delayed while waiting for thyroid function to normalize.

First-Line Emergency Treatment

Current standard initial therapy generally consists of:

High-dose intravenous methylprednisolone

when there is no major contraindication.

A common approach uses:

500–1,000 mg IV methylprednisolone daily for 3 consecutive days

with the exact regimen determined by local protocol and patient factors.

Why IV Steroids Are Preferred

IV glucocorticoids:

• Act rapidly
• Reduce orbital edema
• Reduce muscle swelling
• Can improve optic nerve compression

They are generally preferred over prolonged oral prednisone for:

Acute DON.

What Happens After the First Steroid Course

The patient should be reassessed rapidly for:

• Visual acuity
• Color vision
• Pupils
• Visual fields
• Clinical signs

If optic nerve function fails to improve adequately:

Urgent orbital decompression is indicated.

When Decompression Should Not Be Delayed

Proceed urgently when there is:

• Poor or absent steroid response
• Steroid contraindication
• Progressive visual loss
• Severe apical compression
• Recurrent DON despite medical therapy

The goal is to create additional orbital volume and relieve:

Apical optic nerve pressure.

Which Orbital Walls Are Decompressed

For DON, decompression often targets the:

• Medial orbital wall
• Orbital floor

because these directly relieve apical crowding.

Lateral wall decompression may be added depending on:

• Anatomy
• Proptosis
• Surgical strategy

Why Medial Decompression Is Important

The medial wall provides access to the crowded orbital apex and allows enlarged medial rectus tissue to displace into the:

Ethmoid sinus

thereby reducing pressure on the optic nerve.

Complications of Orbital Decompression

Potential complications include:

• New or worsened diplopia
• Infraorbital numbness
• Sinus complications
• Globe displacement
• CSF leak, rarely
• Orbital hemorrhage
• Rare visual loss

Despite these risks, decompression is potentially sight-saving in DON.

Role of Teprotumumab

Teprotumumab, an IGF-1R inhibitor, is an important treatment for active TED and can substantially reduce:

• Proptosis
• Diplopia
• Soft-tissue inflammation

Case series suggest potential benefit in DON, but:

It should not replace urgent IV glucocorticoids and/or surgical decompression when vision is acutely threatened.

DON requires treatment with therapies capable of rapidly protecting the optic nerve.

Role of Mycophenolate

Mycophenolate is useful for:

Active moderate-to-severe TED

and may reduce inflammatory relapse.

However, it is not generally used as the sole emergency treatment for:

Acute DON.

Role of Orbital Radiotherapy

Orbital radiotherapy may reduce:

• Extraocular muscle inflammation
• Motility restriction

but its effect is relatively slow.

It is therefore:

Not the primary emergency treatment for acute DON.

It may be used as an adjunct in selected active disease.

Important Modern Correction About Radiation

Older management sometimes placed radiation alongside steroids and decompression for acute optic neuropathy.

Modern practice generally prioritizes:

IV glucocorticoids → rapid assessment → orbital decompression when response is inadequate

rather than relying on radiotherapy to rescue an acutely threatened optic nerve.

Role of Rituximab and Other Biologics

Agents such as:

• Rituximab
• Tocilizumab

may be useful in selected refractory active TED.

They are not established first-line rescue treatments for:

Acute DON.

Smoking Cessation

Smoking cessation is essential because smoking increases:

• TED incidence
• Disease activity
• Severity
• Treatment resistance

It is the most important modifiable risk factor.

Thyroid Control

Patients should be maintained as close to:

Euthyroid

as possible.

Both:

• Hyperthyroidism
• Hypothyroidism

may worsen TED.

Management should be coordinated with:

Endocrinology.

Radioactive Iodine Considerations

Radioactive iodine can worsen TED, particularly in patients with:

• Active disease
• Smoking
• High TRAb levels

Glucocorticoid prophylaxis may be appropriate when radioactive iodine is used in high-risk patients.

In established sight-threatening TED, radioactive iodine is generally not the immediate management priority.

Corneal Protection

DON may coexist with severe exposure.

Management can include:

• Preservative-free tears
• Lubricating ointment
• Moisture chamber
• Eyelid taping

Severe epithelial breakdown may require:

• Temporary tarsorrhaphy
• Other protective procedures

Management of Diplopia During Active Disease

Temporary measures include:

• Fresnel prism
• Occlusion
• Ground-in prism for small stable deviations

Definitive strabismus surgery is generally postponed until:

TED is inactive and alignment is stable.

Definitive Rehabilitative Surgery

Once disease is stable, the usual order is:

Orbital decompression → strabismus surgery → eyelid surgery

because each procedure can alter subsequent anatomy.

Monitoring During Acute DON

Patients require very close assessment.

Important parameters include:

• Visual acuity
• Color vision
• RAPD
• Visual fields
• Optic nerve appearance
• Motility
• Corneal status

Clinical reassessment after treatment should occur:

Promptly, often within days rather than weeks.

Steroid Safety

High-dose IV corticosteroids can cause:

• Hyperglycemia
• Hypertension
• Infection
• Psychiatric effects
• Cardiovascular events
• Hepatotoxicity

Very high cumulative methylprednisolone exposure should be avoided.

Liver and Cardiovascular Assessment

Before substantial IV steroid treatment, consider:

• Liver function
• Cardiovascular history
• Blood pressure
• Glucose
• Infection risk

Treatment should still proceed urgently when vision is threatened, while managing systemic risk appropriately.

Why Bisphosphonates Are Not Automatically Required

Older texts recommended oral bisphosphonates routinely for steroid treatment.

Modern osteoporosis prevention is individualized according to:

• Steroid dose and duration
• Age
• Bone density
• Fracture risk
• Calcium/vitamin D status

Brief emergency IV steroid courses do not automatically require bisphosphonate therapy.

Expected Response

When recognized early, treatment can produce substantial recovery in:

• Visual acuity
• Color vision
• Visual fields

Recovery may begin rapidly after:

• IV steroids
• Decompression

Why Vision May Not Fully Recover

Permanent damage can occur if compression causes:

• Axonal loss
• Ischemia
• Optic atrophy

Delayed treatment is therefore associated with worse prognosis.

Chronic Optic Atrophy

Late disease may show:

• Pale optic disc
• Persistent field defects
• Reduced color vision
• Permanent acuity loss

Once established, optic atrophy is:

Irreversible.

Features Suggesting Poorer Prognosis

Concern is greater with:

• Severe initial visual loss
• Marked color vision loss
• Long symptom duration
• Optic disc pallor
• Severe apical crowding
• Delayed decompression
• Recurrent DON

High-Yield Takeaways

• Thyroid optic neuropathy is more commonly termed dysthyroid optic neuropathy (DON) and is a sight-threatening complication of thyroid eye disease.
• The usual mechanism is compression of the optic nerve at the orbital apex by enlarged extraocular muscles.
• DON can occur in hyperthyroid, euthyroid, or hypothyroid patients.
• Important risk factors include smoking, older age, male sex, diabetes, and marked muscle enlargement.
• Severe proptosis is not required; patients with relatively little proptosis but severe apical crowding may be at particularly high risk.
• Early clues include color desaturation, reduced contrast, visual-field abnormalities, and decreased visual acuity.
• An RAPD may be absent when disease is bilaterally symmetric.
• A normal optic disc does not exclude DON because compression usually occurs posteriorly.
• Orbital CT or MRI should demonstrate extraocular muscle enlargement and apical crowding.
• TED classically causes muscle-belly enlargement with relative tendon sparing.
• DON is classified as sight-threatening TED regardless of CAS; a low activity score should not delay treatment.
• Acute treatment generally begins with high-dose IV methylprednisolone.
• If optic nerve function does not improve rapidly, or steroids are contraindicated, urgent orbital decompression is required.
• For DON, decompression commonly targets the medial wall and orbital floor to relieve apical crowding.
• Orbital radiotherapy is too slow to be relied upon as the main emergency rescue treatment for acute DON.
• Teprotumumab is highly relevant to active TED and may help selected DON cases, but it does not replace urgent steroids or decompression when vision is acutely threatened.
• Smoking cessation and maintenance of a euthyroid state are important adjuncts but should never delay optic nerve rescue.
• Patients with suspected DON require rapid neuro-ophthalmic/orbital specialist assessment and close follow-up over days, not routine months-long intervals.
• Prognosis is often good when treatment is early, but established optic atrophy and axonal loss are permanent.